A detailed history of Amundi transactions in Catalent, Inc. stock. As of the latest transaction made, Amundi holds 1,870,278 shares of CTLT stock, worth $119 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,870,278
Previous 1,214,868 53.95%
Holding current value
$119 Million
Previous $68.3 Million 65.83%
% of portfolio
0.04%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$56.16 - $60.96 $36.8 Million - $40 Million
655,410 Added 53.95%
1,870,278 $113 Million
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $42.4 Million - $45.1 Million
790,983 Added 186.6%
1,214,868 $68.3 Million
Q1 2024

May 15, 2024

SELL
$42.56 - $59.82 $1.81 Million - $2.54 Million
-42,439 Reduced 9.1%
423,885 $23.9 Million
Q4 2023

Feb 14, 2024

BUY
$32.18 - $46.57 $4.88 Million - $7.07 Million
151,746 Added 48.24%
466,324 $21 Million
Q3 2023

Nov 14, 2023

SELL
$44.2 - $50.2 $11.6 Million - $13.2 Million
-262,477 Reduced 45.49%
314,578 $14.3 Million
Q2 2023

Aug 14, 2023

SELL
$31.86 - $67.26 $25.9 Million - $54.7 Million
-812,621 Reduced 58.48%
577,055 $25 Million
Q1 2023

May 15, 2023

BUY
$45.44 - $74.26 $24.4 Million - $39.9 Million
537,519 Added 63.08%
1,389,676 $91.3 Million
Q4 2022

Feb 14, 2023

BUY
$41.39 - $81.0 $19.2 Million - $37.6 Million
463,740 Added 119.39%
852,157 $38.3 Million
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $4.26 Million - $6.66 Million
58,902 Added 17.88%
388,417 $31.5 Million
Q2 2022

Aug 15, 2022

SELL
$87.2 - $114.05 $6.12 Million - $8 Million
-70,133 Reduced 17.55%
329,515 $33 Million
Q1 2022

May 16, 2022

BUY
$94.19 - $124.49 $5.27 Million - $6.97 Million
55,972 Added 16.29%
399,648 $45.1 Million
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $1.36 Million - $1.59 Million
11,412 Added 3.43%
343,676 $37.8 Million
Q3 2021

Nov 15, 2021

SELL
$109.17 - $142.35 $1.04 Million - $1.36 Million
-9,572 Reduced 2.8%
332,264 $44.2 Million
Q2 2021

Aug 16, 2021

BUY
$100.34 - $115.69 $34.3 Million - $39.5 Million
341,836 New
341,836 $37 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Amundi Portfolio

Follow Amundi and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.